OHIO
UNIVERSITY-COLLEGE OF OSTEOPATHIC MEDICINE
|
Subject/Title:
|
Policy Number
2.10 |
Serologic Proof of Immunity Required of OU-COM Students
|
Effective Date
August 1,
2005
Revised
Date
March 1, 2007 |
|
|
Department
Academic Affairs
|
|
Issued
by: |
Sarah
McGrew, BSN
Manager of
Clinical and Community Experiences |
Approved by: |
John
Brose, D.O., Dean |
The College of
Osteopathic Medicine requires positive serologic proof of immunity in
the form of positive antibody titers for measles, mumps, rubella,
hepatitis B and varicella. This information is required to uphold
Affiliation Agreements between OU-COM and clinical rotation sites.
Following
matriculation, students are required to provide Academic Affairs with
official documentation of serologic proof of immunity to:
·
Measles, mumps and rubella. If
a student is found to have a negative serology after two documented
doses of MMR, one additional dose of MMR will be administered.
Post-vaccination serologic testing will cease at that time, based on the
Centers of Disease Control and Prevention definition of “immune”.
·
Hepatitis B (>10 ml/IU titer required).
Students with an antibody
titer <10 ml/IU for hepatitis B have two options. They may:
1) Choose to be revaccinated
with one dose of hepatitis B and have another titer drawn after one
month, or they may:
2) Choose to repeat the
3-dose series and have the titer drawn 1 – 2 months after the 3rd
dose. If the titer is again negative following Option 1, two additional
doses of hepatitis B vaccine will be given, one at the time of the
negative titer and one 5 months later. Antibody titers will be redrawn
1 month after the last dose of vaccine.
If the titer is <10 mIU/ml
following a second series of the vaccine (Option 1 or Option 2), the
student will be tested for the presence of Hepatitis B virus. If that
test is negative, the student will be labeled a “non-responder” and
instructed on procedures to follow if exposure to Hepatitis B occurs.
According to the CDC, in the occupational setting, two doses of
hepatitis B immune globulin (HBIG) initiated within one (1) week
following percutaneous exposure to HBsAG-positive blood provides an
estimated 75% protection from HBV infection.
If the test for hepatitis B
virus is positive (HBsAg-positive and HBeAg-positive), the student’s
enrollment status will not be affected. According to the CDC, there is
one caveat for HBV-infected health professionals. Those who are HBsAg-positive
and HBeAg-positive should not perform exposure-prone procedures (e.g.,
gynecologic, cardiothoracic surgery) unless they have sought counsel
from an expert review panel and been advised under what circumstances,
if any, they may continue to perform these procedures. Such
circumstances might include notifying prospective patients of the health
professional's seropositivity before they undergo exposure-prone
invasive procedures.
•Varicella.
Students with negative antibody titers to varicella must obtain 2
varicella vaccinations at least 4 but no more than 8 weeks apart:
Antibody titers in the equivocal range will be accepted as positive, as
commercially available tests may not be sensitive enough to detect
low levels of antibody. Post- vaccination serologic testing
will cease at that time, based on the ACIP definition of “immune”.”.
Students who are vaccinated
will be instructed that they may develop a rash 2-6 weeks after
vaccination and that this rash may be either a localized rash at the
site of vaccination or a diffuse varicella-like rash. Either rash may be
atypical with macules or papules rather than vesicles. Students will be
instructed to report immediately to the CCE Program Coordinator if a
rash develops. Students with either an injection site rash or a
generalized rash will have their CCE’s placed on hold until the rash
resolves (usually in 2-3 days). The CCE Program Manager must verify that
the rash has resolved and they are not potentially infectious to others
before being allowed to resume CCE activities.
Students who are accepted to OU-COM and
students on the alternate list will receive a letter explaining
serologic proof of immunity requirements. Students are expected to
receive tests to document serologic proof of immunity prior to the first
Clinical and Community Experience. Time will be made available for
testing to take place during the first 2 weeks of class. Charges for
antibody titers are the responsibility of the student.
The Office of Academic Affairs
maintains immunization and serologic proof of immunity records and
assists students as needed. A copy of the student immunization record
(including serologic proof of immunity) is sent to the CORE where each
Year III student is assigned. It is the responsibility of the CORE
Assistant Dean to oversee student immunization requirements in Years III
and IV, including those students from other osteopathic medical colleges
who are in the CORE system.
|
Last updated:
12/17/2007
|